Prospective Cohort Real-World Study on Neuroendocrine Tumor Patient's Quality of Life During Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE.

Ramim, Jayda Eiras; Matheos de Lima, Beatriz Arruda; Bulzico, Daniel Alves; Pujatti, Priscilla Brunelli; Bergmann, Anke

Ramim, Jayda Eiras; Matheos de Lima, Beatriz Arruda; Bulzico, Daniel Alves; Pujatti, Priscilla Brunelli; Bergmann, Anke.

Affiliation

Matheos de Lima BA; From the Nuclear Medicine Section.
Bulzico DA; From the Nuclear Medicine Section.
Pujatti PB; From the Nuclear Medicine Section.
Bergmann A; Clinical Epidemiology Program, National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Pancreas ; 51(7): 784-789, 2022 08 01.

Article in En | MEDLINE | ID: mdl-36395404

Subject(s)

Neuroendocrine Tumors; Adult; Humans; Middle Aged; Neuroendocrine Tumors/radiotherapy; Neuroendocrine Tumors/pathology; Prospective Studies; Quality of Life; Radioisotopes/therapeutic use; Receptors, Peptide; Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors Type of study: Etiology_studies / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Pancreas Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google